Pediatric leukemia treatment has made enormous steps forward in recent years. An in-depth conversation with one of world’s top experts in child leukemia treatment. Dr. Shai Izraeli discusses precision medicine era in child cancer treatment. Biography and introduction. Hello from Tel Aviv! Dr. Anton Titov, MD. We are with Dr. Shai Izraeli, MD. He is Director of the Department of Hematology-Oncology at Schneider Children's Medical Center. Dr. Shai Izraeli, MD. is Professor of Molecular Genetics & Biochemistry, Sackler Faculty of Medicine, Tel Aviv University. Dr. Izraeli obtained his MD from Hebrew University Medical School, Jerusalem. He received Masters in Pediatrics from Tel Aviv University. Dr. Shai Izraeli, MD did fellowship in Pediatric Hematology Oncology and molecular leukemia research at the National Cancer Institute, in Bethesda, United States. Dr. Shai Izraeli was also a Director of the Unit of Functional Genomics. He was a Director of Childhood Leukemia and Cancer Research at Sheba Medical Center Tel Hashomer, Israel. Clinical and research interests of Dr. Izraeli include diagnosis and treatment of child leukemia. Dr. Shai Izraeli, MD did breakthrough research in Molecular Biology and Genomics that has led to the discovery of a new form of childhood leukemia. Dr. Izraeli is Co-Chair of the Israeli National Study of childhood acute lymphoblastic leukemia. Dr. Shai Izraeli, MD is a Chair of the Biology and Diagnosis committee of the international clinical trial group of childhood hematological malignancies Dr. Izraeli has authored and co-authored over 170 peer-reviewed publications in international medical journals. Dr. Shai Izraeli, MD presented numerous talks at international conferences on child leukemia research and treatment. Dr. Anton Titov, MD. Dr. Izraeli, hello and welcome! Hello, good to see you!